The Targeting RNA congress will present the latest breakthroughs in modulation of RNA (splicing/non-coding/micro) directly with small molecules and through epigenetics.
25.09.2019 | Science news
The Targeting RNA congress will present the latest breakthroughs in modulation of RNA (splicing/non-coding/micro) directly with small molecules and through epigenetics. It is a significant event for the world of chemistry, as it brings together leaders in academics and industry who are building platforms to identify and validate targets in order to assess in disease relevance approaches in the relatively untapped RNA world.
“This meeting is an excellent opportunity to interact with one of the best collections of thought leaders and drug discovery experts in the field of epitranscriptomics, and I am looking forward to exchanging strategic insights with my colleagues aiming at unlocking an entire class of previously undruggable targets” – Dr. Gerhard Mueller, Chief Scientific Officer, Gotham Therapeutics
Our CEO & Co-founder, Dr Kamal Azzaoui, will be speaking at the conference.
Come and meet us there!